CStone Pharmaceuticals (FRA:PH4) Scaled Net Operating Assets : 0.00 (As of Jun. 2023)

View and export this data going back to 2019. Start your Free Trial

What is CStone Pharmaceuticals Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

CStone Pharmaceuticals's operating assets for the quarter that ended in Jun. 2023 was €0.00 Mil. CStone Pharmaceuticals's operating liabilities for the quarter that ended in Jun. 2023 was €0.00 Mil. CStone Pharmaceuticals's Total Assets for the quarter that ended in Dec. 2022 was €221.85 Mil. Therefore, CStone Pharmaceuticals's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2023 was 0.00.

CStone Pharmaceuticals Scaled Net Operating Assets Historical Data

The historical data trend for CStone Pharmaceuticals's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CStone Pharmaceuticals Scaled Net Operating Assets Chart

CStone Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Scaled Net Operating Assets

Get a 7-Day Free Trial

-0.16

-0.12

-0.10

-0.13

-0.12

CStone Pharmaceuticals Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Scaled Net Operating Assets	Get a 7-Day Free Trial									-0.13	-	-0.15	-	-

Competitive Comparison of CStone Pharmaceuticals's Scaled Net Operating Assets

For the Biotechnology subindustry, CStone Pharmaceuticals's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CStone Pharmaceuticals's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CStone Pharmaceuticals's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where CStone Pharmaceuticals's Scaled Net Operating Assets falls into.

CStone Pharmaceuticals Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

CStone Pharmaceuticals's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(81.594	-	108.1)	/	221.85
=	-0.12

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	213.447	-	131.853
=	81.594

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	154.777	-	28.785	-	17.892
=	108.1

CStone Pharmaceuticals's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Jun. 2023 )
=	(Operating Assets (Q: Jun. 2023 )	-	Operating Liabilities (Q: Jun. 2023 ))	/	Total Assets (Q: Dec. 2022 )
=	(0	-	0)	/	221.85
=	0.00

where

	Operating Assets		(Q: Jun. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	0	-	0
=	0

	Operating Liabilities		(Q: Jun. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	0	-	0	-	0
=	0

CStone Pharmaceuticals Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of CStone Pharmaceuticals's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

CStone Pharmaceuticals (FRA:PH4) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CStone Pharmaceuticals (FRA:PH4) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

CSPHF:USA 02616:Hong Kong PH4:Germany

Address

218 Xinghu Street, C1 Building, North Block, Suzhou Industrial Park, Shanghai, CHN, 215123

Website

https://www.cstonepharma.com

CStone Pharmaceuticals is engaged in the development and commercialization of innovative tumor immunotherapy and molecular-targeted drugs. It has been operating in one reportable segment, the research and development of complex biopharmaceutical products.

CStone Pharmaceuticals (FRA:PH4) Headlines

No Headlines